Back

A systematic review and meta-analysis of health-related quality of life (HRQoL) outcomes in randomised controlled trials for pulmonary arterial hypertension (PAH)

1 September 2024 (17:00 - 17:50)
Organised by: Logo
Congress Presentation Part of: Pulmonary hypertension: insights from registries, retrospective data sets, and meta-analyses Pulmonary Hypertension ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Frances Varian

British Cardiovascular Society, London (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Improving morbidity and mortality in patients with pulmonary hypertension: insights from a nation-wide registry
Professor C. Kaymaz (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Real-world evidence on pulmonary arterial hypertension: interim analysis from the Italian observational study INSPECTIO
Associate Professor M. D'Alto (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Idiopathic pulmonary arterial hypertension, associated with connective tissue disease and comorbidities: prognostic differences? Results the Spanish Registry of pulmonary hypertension (REHAP Registry)
Doctor R. Bravo-Marques (Marbella, ES)
Abstract Slides Video
Presentation thumbnail
Clinical, echocardiographic and haemodynamic predictors of morbidity and mortality in pulmonary hypertension: a nation-wide registry
Professor C. Kaymaz (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
The importance of comorbidities in idiopathic and associated with connective tissue disease pulmonary arterial hypertension: from the Spanish Registry of Pulmonary Hypertension (REHAP Registry)
Doctor R. Bravo-Marques (Marbella, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Pulmonary hypertension: insights from registries, retrospective data sets, and meta-analyses

The Event

Event poster

ESC Congress 2024

1 September 2024 17:00 CET
You may be interested in
thumbnail
Congress Presentation
Hemodynamic changes with pulmonary arterial hypertension targeted therapies: a meta-analysis of 3898 treatment-naive patients
thumbnail
Congress Presentation
Representativeness of randomized clinical trial criteria among the real-world patients with pulmonary arterial hypertension: an analysis from the FOCUS-PAH registry
thumbnail
Congress Presentation
Measuring quality of life in cardiovascular diseases: findings from a scoping review on the use and relevance of patient-reported outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources